Published in Nat Genet on January 01, 1999
Inferring tumor progression from genomic heterogeneity. Genome Res (2009) 6.09
Evaluation of non-formalin tissue fixation for molecular profiling studies. Am J Pathol (2002) 2.38
Tracing the tumor lineage. Mol Oncol (2010) 1.56
In silico cloning of novel endothelial-specific genes. Genome Res (2000) 1.42
High-resolution quantification of specific mRNA levels in human brain autopsies and biopsies. Genome Res (2000) 1.22
Down-regulation of growth arrest DNA damage-inducible gene 45beta expression is associated with human hepatocellular carcinoma. Am J Pathol (2003) 1.17
Squamous Cell Carcinoma - Similarities and Differences among Anatomical Sites. Am J Cancer Res (2011) 1.13
Integrin gene expression profiles of human hepatocellular carcinoma. World J Gastroenterol (2002) 1.11
Molecular profiling of clinical tissue specimens: feasibility and applications. Am J Pathol (2000) 1.00
Molecular profiling of clinical tissues specimens: feasibility and applications. J Mol Diagn (2000) 0.98
cDNA arrays and immunohistochemistry identification of CD10/CALLA expression in hepatocellular carcinoma. Am J Pathol (2001) 0.97
Absence of annexin I expression in B-cell non-Hodgkin's lymphomas and cell lines. BMC Cancer (2004) 0.94
Identification and classification of acute cardiac rejection by intragraft transcriptional profiling. Circulation (2011) 0.89
Identification of unique expression signatures and therapeutic targets in esophageal squamous cell carcinoma. BMC Res Notes (2012) 0.88
Combined histomorphometric and gene-expression profiling applied to toxicology. Genome Biol (2003) 0.86
Nanomedicine: application areas and development prospects. Int J Mol Sci (2011) 0.84
Integrating complex genomic datasets and tumour cell sensitivity profiles to address a 'simple' question: which patients should get this drug? BMC Med (2009) 0.79
A Mechanistic Beta-Binomial Probability Model for mRNA Sequencing Data. PLoS One (2016) 0.76
Gene expression profiling in familial adenomatous polyposis adenomas and desmoid disease. Hered Cancer Clin Pract (2007) 0.76
Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science (1997) 7.95
Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. Science (1997) 6.66
Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene (2001) 4.40
Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice. Proc Natl Acad Sci U S A (1997) 3.27
The cancer genome anatomy project: building an annotated gene index. Trends Genet (2000) 3.02
Laser-capture microdissection: opening the microscopic frontier to molecular analysis. Trends Genet (1998) 2.60
Immuno-LCM: laser capture microdissection of immunostained frozen sections for mRNA analysis. Am J Pathol (1999) 2.59
A microdissection technique for archival DNA analysis of specific cell populations in lesions < 1 mm in size. Am J Pathol (1995) 2.59
A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors. Proc Natl Acad Sci U S A (2001) 2.57
Somatic mutation of the MEN1 gene in parathyroid tumours. Nat Genet (1997) 1.90
Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas. Cancer Res (1997) 1.82
A transcript map for the 2.8-Mb region containing the multiple endocrine neoplasia type 1 locus. Genome Res (1997) 1.82
Evidence of independent origin of multiple tumors from patients with prostate cancer. J Natl Cancer Inst (1998) 1.81
Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosome 8p12-21. Cancer Res (1996) 1.78
Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states. Hum Mol Genet (1997) 1.77
von Hippel-Lindau gene deletion detected in the stromal cell component of a cerebellar hemangioblastoma associated with von Hippel-Lindau disease. Hum Pathol (1997) 1.74
Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung. Hum Mol Genet (1997) 1.70
Identical allelic loss on chromosome 11q13 in microdissected in situ and invasive human breast cancer. Cancer Res (1995) 1.57
Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma. Cancer Res (2000) 1.50
Immunohistochemical analysis of cathepsins D, B, and L in human breast cancer. Hum Pathol (1994) 1.45
Loss of heterozygosity on chromosome 13 is associated with advanced stage prostate cancer. J Urol (1999) 1.41
Cathepsin B expression in colorectal carcinomas correlates with tumor progression and shortened patient survival. Am J Pathol (1994) 1.38
Necropsy as a research method in the age of molecular pathology. Lancet (1995) 1.37
Mutations of the MEN1 tumor suppressor gene in pituitary tumors. Cancer Res (1997) 1.31
Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias. Recent Prog Horm Res (1999) 1.29
Layered expression scanning: rapid molecular profiling of tumor samples. Cancer Res (2000) 1.24
Loss of heterozygosity at 11q13: analysis of pituitary tumors, lung carcinoids, lipomas, and other uncommon tumors in subjects with familial multiple endocrine neoplasia type 1. J Clin Endocrinol Metab (1997) 1.23
Construction of a representative cDNA library from prostatic intraepithelial neoplasia. Cancer Res (1996) 1.23
Allelic loss in esophageal squamous cell carcinoma patients with and without family history of upper gastrointestinal tract cancer. Clin Cancer Res (1999) 1.20
Linkage map of human chromosome 9 microsatellite polymorphisms. Genomics (1992) 1.19
Proteomic profiling of the cancer microenvironment by antibody arrays. Proteomics (2001) 1.19
Identification of novel regions of allelic loss from a genomewide scan of esophageal squamous-cell carcinoma in a high-risk Chinese population. Genes Chromosomes Cancer (2000) 1.19
Proteomic analysis of laser capture microdissected human prostate cancer and in vitro prostate cell lines. Electrophoresis (2000) 1.18
Genetic analysis of synchronous mucinous tumors of the ovary and appendix. Hum Pathol (1996) 1.17
Development of a prostate cDNA microarray and statistical gene expression analysis package. Mol Carcinog (2000) 1.16
Frequent inactivation of the TP53 gene in esophageal squamous cell carcinoma from a high-risk population in China. Clin Cancer Res (2001) 1.14
An improved method for construction of directionally cloned cDNA libraries from microdissected cells. Cancer Res (1998) 1.13
Generation and genetic characterization of immortal human prostate epithelial cell lines derived from primary cancer specimens. Cancer Res (1997) 1.10
The multiple endocrine neoplasia type I gene locus is involved in the pathogenesis of type II gastric carcinoids. Gastroenterology (1997) 1.10
Allelic deletions on chromosome 11q13 in multiple endocrine neoplasia type 1-associated and sporadic gastrinomas and pancreatic endocrine tumors. Cancer Res (1997) 1.08
Analysis of loss of heterozygosity on chromosome 11q13 in atypical ductal hyperplasia and in situ carcinoma of the breast. Am J Pathol (1997) 1.07
Barrett's esophagus: metaplastic cells with loss of heterozygosity at the APC gene locus are clonal precursors to invasive adenocarcinoma. Cancer Res (1996) 1.06
Identification of a unique epigenetic sub-microenvironment in prostate cancer. J Pathol (2007) 1.04
Genetic progression and heterogeneity associated with the development of esophageal squamous cell carcinoma. Cancer Res (2001) 1.03
Expression studies and mutational analysis of the androgen regulated homeobox gene NKX3.1 in benign and malignant prostate epithelium. J Urol (2001) 1.02
Allelic loss on chromosome arm 8p: analysis of sporadic epithelial ovarian tumors. Gynecol Oncol (1999) 1.01
High frequency allelic loss on chromosome 17p13.3-p11.1 in esophageal squamous cell carcinomas from a high incidence area in northern China. Carcinogenesis (2000) 1.01
Molecular profiling of clinical tissue specimens: feasibility and applications. Am J Pathol (2000) 1.00
Transcript mapping in a 46-kb sequenced region at the core of 12q13.3 amplification in human cancers. Genomics (1997) 0.99
Eighteen new polymorphic markers in the multiple endocrine neoplasia type 1 (MEN1) region. Hum Genet (1997) 0.99
Gene discovery in oral squamous cell carcinoma through the Head and Neck Cancer Genome Anatomy Project: confirmation by microarray analysis. Oral Oncol (2003) 0.99
Histopathology and molecular biology of ovarian epithelial tumors. Ann Diagn Pathol (1998) 0.98
Molecular profiling of clinical tissues specimens: feasibility and applications. J Mol Diagn (2000) 0.98
Molecular regulation, membrane association and secretion of tumor cathepsin B. APMIS (1999) 0.98
Identification of a novel transcript up-regulated in a clinically aggressive prostate carcinoma. Urology (1997) 0.97
Sensitive immunoassay of tissue cell proteins procured by laser capture microdissection. Am J Pathol (2000) 0.96
A YAC contig containing the reeler locus with preliminary characterization of candidate gene fragments. Genomics (1995) 0.94
Printing of protein microarrays via a capillary-free fluid jetting mechanism. Proteomics (2005) 0.93
Gene expression profiles in squamous cell carcinomas of the oral cavity: use of laser capture microdissection for the construction and analysis of stage-specific cDNA libraries. Oral Oncol (2000) 0.93
Allelic deletions on chromosome 11q13 in multiple tumors from individual MEN1 patients. Cancer Res (1996) 0.92
Characterization of intracellular prostate-specific antigen from laser capture microdissected benign and malignant prostatic epithelium. Clin Cancer Res (2000) 0.91
Loss of heterozygosity on the short arm of chromosome 8 in male breast carcinomas. Cancer Res (1995) 0.90
Cathepsin D and prognosis in breast cancer: one piece of a larger puzzle? Hum Pathol (1996) 0.89
PA-1, a human cell model for multistage carcinogenesis: oncogenes and other factors. Anticancer Res (1988) 0.89
Detection of the von Hippel-Lindau gene deletion in cytologic specimens using microdissection and the polymerase chain reaction. Acta Cytol (1994) 0.89
von Hippel-Lindau disease gene deletion detected in microdissected sporadic human colon carcinoma specimens. Hum Pathol (1996) 0.88
Common genetic variants of TP53 and BRCA2 in esophageal cancer patients and healthy individuals from low and high risk areas of northern China. Cancer Detect Prev (2003) 0.87
Differential cytokine mRNA expression in human labial minor salivary glands in primary Sjögren's syndrome. Autoimmunity (1998) 0.87
Multiple phenotypic divergence of mammary adenocarcinoma cell clones. I. In vitro and in vivo properties. Clin Exp Metastasis (1985) 0.86
The gene for multiple endocrine neoplasia type 1: recent findings. Bone (1999) 0.85
The Cancer Genome Anatomy Project: EST sequencing and the genetics of cancer progression. Neoplasia (1999) 0.85
Haplotype analysis defines a minimal interval for the multiple endocrine neoplasia type 1 (MEN1) gene. Cancer Res (1997) 0.85
Analysis of recurrent germline mutations in the MEN1 gene encountered in apparently unrelated families. Hum Mutat (1998) 0.85
Molecular profiling of tissue samples using laser capture microdissection. Expert Rev Mol Diagn (2001) 0.85
Modulation of differentiation in PA-1 human teratocarcinoma cells after N-ras oncogene-induced tumorigenicity. Oncogene (1991) 0.83
9p monosomy in a patient with Gilles de la Tourette's syndrome. Neurology (1991) 0.83
Correlation of increased levels of Ha-ras T24 protein with extent of loss of gap junction function in rat liver epithelial cells. Mol Carcinog (1992) 0.82
Susceptibility to ras oncogene transformation is coregulated with signal transduction through growth factor receptors. Oncogene (1991) 0.82
Proteomic analysis of nuclei dissected from fixed rat brain tissue using expression microdissection. Anal Chem (2013) 0.81
Allelic loss on chromosome bands 13q11-q13 in esophageal squamous cell carcinoma. Genes Chromosomes Cancer (2001) 0.81
Loss of heterozygosity on chromosome 11q13 in microdissected human male breast carcinomas. J Natl Cancer Inst (1995) 0.81
Picoliter-scale protein microarrays by laser direct write. Biotechnol Prog (2002) 0.80
TIMP-2 mediates cell surface binding of MMP-2. Adv Exp Med Biol (1996) 0.80
Molecular profiling of human cancer: new opportunities. Curr Opin Mol Ther (1999) 0.80
Allelic deletion at chromosome 9p21(p16) and 17p13(p53) in microdissected sporadic dysplastic nevus. Hum Pathol (1998) 0.80
cDNA sequencing and analysis of POV1 (PB39): a novel gene up-regulated in prostate cancer. Genomics (1998) 0.80
Microdissection, microchip arrays, and molecular analysis of tumor cells (primary and metastases). Semin Radiat Oncol (1998) 0.80
Analysis of mRNA quality in freshly prepared and archival Papanicolaou samples. Acta Cytol (1999) 0.79
The role of tissue microdissection in cancer research. Cancer J (2001) 0.79
MEN1 gene mutation analysis of high-grade neuroendocrine lung carcinoma. Genes Chromosomes Cancer (2000) 0.79
Chromosome 16 allelic loss analysis of a large set of microdissected prostate carcinomas. J Urol (1999) 0.77
Germline and somatic mutation of the gene for multiple endocrine neoplasia type 1 (MEN1). J Intern Med (1998) 0.77
Quantitative study of a proposed interstitial del (20p 12.2) in multiple endocrine neoplasia (MEN-II). Anticancer Res (1986) 0.75